Chinese

advanced search

News & Events

Home News & Events Content

Professor Yuan Zuyi publishes CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic in Circulation

Updated: Apr 12, 2020
From: Department of Science and Technology
Edited by: Liu Huiting
Hits:

Recently, Professor Yuan Zuyi from Department of Cardiology of the First Affiliated Hospital of Xi 'an Jiaotong University (XJTU), as a major contributor, drafted and published CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic in Circulation, ranking 1st in the field of cardiovascular diseases worldwide.

The severe situation of COVID-19, especially the recent rapid spread of COVID-19 in Europe and the United States, poses fatal threats to patients with cardiovascular diseases. However, there is currently no English-version guidelines for the diagnosis and treatment of severe emergent cardiovascular diseases during the COVID-19 pandemic. Based on the frontline experience of our hospital in diagnosing and treating the most severe COVID-19 patients in Shaanxi province, Professor Yuan Zuyi, as Head of Coronary Heart Disease Group of Chinese Medical Association, led all members to overnight translate their valuable experience accumulated during the diagnosis and treatment of COVID-19 into English-version guidelines. The English-version expert consensus was accepted by American Heart Association in only two days after submission, aiming to serve as guidelines for clinical work of cardiologists worldwide during the outbreak of COVID-19 pandemic.

Our hospital is mainly responsible for drafting the chapter of the emergent treatment of acute myocardial infarction. This article starts with the risk assessment ofpatients and the protection of medical staff, elaborates the rescue measures and medication guidance adopted by cardiovascular physicians during the diagnosis and treatment of COVID-19, properly classifies the treatment strategies for patients with severe emergent cardiovascular diseases, and unreservedly shares ‘China's experience’ with physicians worldwide.

Previous:The second-batch medical aid team from Shaanxi Province publishes research outcomes in top-notch journals in the field of infection
Next:Our hospital hosts Online Science Popularization Course for COVID-19 Prevention and Control Knowledge (U.S. and Canada session)

Copyright (c) 2011, First Affiliated Hospital of Xi 'an Jiaotong University Shaanxi ICP for 12009712-3